IL1B and breast cancer: Interestingly, the levels of interleulin-1β (IL-1β) and tumor-necrosis factor α (TNFα) are higher in metastatic ER+ BC patients, where these cytokines activate the NF-κB and lead to endocrine resistance (417, 418).